Codes / ICD10CM / K12.31

K12.31 Oral mucositis (ulcerative) due to antineoplastic therapy

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy

Summary

Oral mucositis (ulcerative) due to antineoplastic therapy is a condition marked by inflammation and ulceration of the oral mucosa, resulting from cancer treatment. It can cause significant pain, difficulty eating, drinking, or speaking, and may impact quality of life. The severity of symptoms varies, ranging from mild irritation to severe ulceration.

Causes

This condition is directly caused by antineoplastic therapy, such as chemotherapy or radiation, which damages rapidly dividing cells in the oral mucosa. The therapy disrupts the mucosal barrier, leading to inflammation and ulceration.

Risk Factors

  • Type and intensity of antineoplastic therapy (e.g., high-dose chemotherapy, radiation to the head/neck).
  • Pre-existing oral conditions (e.g., poor hygiene, dental issues).
  • Weakened immune system from treatment.
  • History of previous mucositis.
  • Use of certain medications alongside antineoplastic therapy.

Symptoms

  • Pain, burning, or soreness in the mouth.
  • Redness, swelling, or ulceration of oral tissues.
  • Difficulty eating, drinking, or speaking.
  • White or yellow patches on the mucosa.
  • Bleeding or tenderness of the gums.

Diagnosis

Diagnosis is based on clinical evaluation of the oral cavity, patient history of antineoplastic therapy, and symptom assessment. A healthcare provider examines the mouth for ulceration, inflammation, and other signs consistent with the condition.

Treatment Options

Treatment focuses on managing symptoms and promoting healing. Options may include pain relief (e.g., topical anesthetics), oral care (e.g., gentle hygiene, mouth rinses), nutritional support, and medications to reduce inflammation or prevent infection.

Prognosis and Follow-Up

Prognosis depends on the severity of mucositis and the type of antineoplastic therapy. Symptoms often improve after treatment ends, but follow-up care may be needed to monitor healing and address complications. Regular oral assessments are recommended during therapy.

Complications

  • Severe pain impacting nutrition and hydration.
  • Infection (e.g., bacterial, fungal) due to mucosal breakdown.
  • Delay or modification of cancer treatment.
  • Weight loss or malnutrition.

Lifestyle & Prevention

  • Maintain good oral hygiene (gentle brushing, flossing).
  • Avoid irritants (e.g., tobacco, alcohol, spicy foods).
  • Stay hydrated and eat soft, non-acidic foods.
  • Use recommended mouth rinses or protective agents as advised.
  • Attend regular dental check-ups before starting therapy.

When to Seek Professional Help

Seek care if symptoms worsen, pain becomes unmanageable, or signs of infection (e.g., fever, increased swelling) appear. Prompt evaluation is important to adjust treatment and prevent complications.

Tips for Medical Coders

Document the link between oral mucositis and antineoplastic therapy clearly. Include details on the type of therapy (e.g., chemotherapy, radiation) and the timing of mucositis relative to treatment. Ensure the code K12.31 is used when the condition is explicitly due to antineoplastic therapy.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

K12.31 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.